What is QUANTUM GENESIS's earnings per share (EPS)?

QUANTUM GENESIS (QGAI) reported diluted earnings per share of $-0.01 for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

QUANTUM GENESIS Financials

QGAI

Source SEC Filings (10-K/10-Q) Updated Jan 31, 2026 Currency USD FYE July

This page shows QUANTUM GENESIS (QGAI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI QGAI FY2025 2026-04-22

By FY2025, liabilities vastly exceeded assets, leaving the company closer to a balance-sheet shell than an operating business.

From FY2024 to FY2025, total assets fell from $10K to $184. At the same time, total liabilities climbed from $353K to $491K, meaning the shrinking entity was being carried by obligations rather than by any meaningful operating asset base.

Cash dropped from $5K to $184. Meanwhile, share count rose from 34.8M to 39.0M shares, suggesting any equity raised did not rebuild liquidity or restore operating capacity.

Some figures from recent filings were inconsistent and were omitted from this summary.

Financial Health Signals

Financial Profile 17/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of QUANTUM GENESIS's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

100

QUANTUM GENESIS carries a low D/E ratio of -1.00, meaning only $-1.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

QUANTUM GENESIS's current ratio of 0.00 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

QUANTUM GENESIS generated $0 in revenue in fiscal year 2025.

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$-0.01

YoY+0.0%

QUANTUM GENESIS earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$184

YoY-96.4%

QUANTUM GENESIS held $184 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

39M

YoY+12.0%

QUANTUM GENESIS had 39M shares outstanding in fiscal year 2025. This represents an increase of 12.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

QGAI Income Statement

Metric	FY25	FY24	FY18	FY17	FY16
Revenue	$0	$0-100.0%	$94K-27.0%	$128K+5.6%	$121K
Cost of Revenue	N/A	N/A	$89K-15.6%	$106K+1.9%	$104K
Gross Profit	N/A	N/A	$4K-81.1%	$22K+27.7%	$17K
R&D Expenses	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	$32K	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	$15K	N/A	N/A	N/A
Income Tax	$0	$0	N/A	-$6K	N/A
Net Income	N/A	N/A	-$28K+14.3%	-$33K-777.9%	-$4K
EPS (Diluted)	$-0.010.0%	$-0.01	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$0	$0	N/A	$0	$0	$0	N/A	$0
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	$3K+111.5%	$2K	N/A	$8K
Operating Income	N/A	N/A	N/A	N/A	-$25K+59.7%	-$61K	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	$5K+14.9%	$5K	N/A	$4K
Income Tax	$0	$0	N/A	$0	$0	$0	N/A	$0
Net Income	N/A	N/A	N/A	N/A	-$30K+54.5%	-$66K	N/A	-$64K
EPS (Diluted)	$-0.12	$0.00	N/A	N/A	$0.00	$0.00	N/A	N/A

QGAI Balance Sheet

Metric	FY25	FY24	FY18	FY17	FY16
Total Assets	$184-98.2%	$10K-36.9%	$16K-0.7%	$16K-29.1%	$23K
Current Assets	$184-98.2%	$10K+76.2%	$6K+1.7%	$6K-51.4%	$11K
Cash & Equivalents	$184-96.4%	$5K+942.8%	$486+14.6%	$424-94.4%	$8K
Inventory	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$491K+38.9%	$353K+353222.0%	$1000.0%	$1000.0%	$100
Current Liabilities	$491K+67.3%	$293K+293198.0%	$1000.0%	$1000.0%	$100
Long-Term Debt	N/A	N/A	N/A	N/A	N/A
Total Equity	-$491K-42.9%	-$343K-2281.8%	$16K-0.7%	$16K-29.3%	$22K
Retained Earnings	-$5.7M-4.6%	-$5.4M-18737.6%	-$29K-0.4%	-$29K-29.5%	-$22K

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$59-67.9%	$184-68.5%	$5840.0%	$584	N/A	N/A	$10K	N/A
Current Assets	$59-67.9%	$184-68.5%	$5840.0%	$584	N/A	N/A	$10K	N/A
Cash & Equivalents	$59-67.9%	$184-68.5%	$5840.0%	$584-66.7%	$2K-65.4%	$5K	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$418K-14.7%	$491K+11.2%	$441K+9.5%	$403K	N/A	N/A	$293K	N/A
Current Liabilities	$418K-14.7%	$491K+11.2%	$441K+9.5%	$403K	N/A	N/A	$293K	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$418K+14.7%	-$491K-11.3%	-$441K-9.5%	-$403K-7.9%	-$373K-8.7%	-$343K-21.2%	-$283K-105.9%	$4.8M
Retained Earnings	-$10.0M-76.1%	-$5.7M-0.9%	-$5.6M-0.7%	-$5.6M	N/A	N/A	-$5.4M	N/A

QGAI Cash Flow Statement

Metric	FY25	FY24	FY18	FY17	FY16
Operating Cash Flow	N/A	N/A	-$3K+92.8%	-$38K-896.0%	-$4K
Capital Expenditures	N/A	N/A	$12K	N/A	N/A
Free Cash Flow	N/A	N/A	-$15K	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	$41K	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	N/A	N/A	N/A	N/A	-$15K+58.6%	-$35K-160.6%	-$13K	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	$11K-72.1%	$40K+198.3%	$13K	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

QGAI Financial Ratios

Metric	FY25	FY24	FY18	FY17	FY16
Gross Margin	N/A	N/A	4.5%-12.9pp	17.4%+3.0pp	14.4%
Operating Margin	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	-30.1%-4.5pp	-25.6%-22.6pp	-3.1%
Return on Equity	N/A	N/A	-179.0%+28.3pp	-207.3%-190.6pp	-16.7%
Return on Assets	N/A	N/A	-177.9%+28.2pp	-206.0%-189.4pp	-16.6%
Current Ratio	0.00-0.0	0.03-56.7	56.76+1.0	55.80-58.9	114.70
Debt-to-Equity	-1.00+0.0	-1.03-1.0	0.010.0	0.010.0	0.00
FCF Margin	N/A	N/A	-15.7%	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-1.3%
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	0.000.0	0.000.0	0.000.0	0.00	N/A	N/A	0.03	N/A
Debt-to-Equity	-1.000.0	-1.000.0	-1.000.0	-1.00	N/A	N/A	-1.04	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$491K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is QUANTUM GENESIS's annual revenue?

QUANTUM GENESIS (QGAI) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

What are QUANTUM GENESIS's total assets?

QUANTUM GENESIS (QGAI) had $184 in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does QUANTUM GENESIS have outstanding?

QUANTUM GENESIS (QGAI) had 39M shares outstanding as of fiscal year 2025.

What is QUANTUM GENESIS's current ratio?

QUANTUM GENESIS (QGAI) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is QUANTUM GENESIS's debt-to-equity ratio?

QUANTUM GENESIS (QGAI) had a debt-to-equity ratio of -1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is QUANTUM GENESIS's debt-to-equity ratio negative or unusual?

QUANTUM GENESIS (QGAI) has negative shareholder equity of -$491K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is QUANTUM GENESIS?

QUANTUM GENESIS (QGAI) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.